Xantomit®

Mitoxantrone

Product Information

  • Proprietary Name: Xantomit®
  • Generic Name: Mitoxantrone
  • Dosage Form: Vial
  • Strengths: 20 mg/10 ml
  • Indications: Multiple Sclerosis, Prostate Cancer, Hepatocellular Carcinoma, Breast Cancer, Non-Hodgkin’s Lymphoma, Acute Non-Lymphocytic Leukemia (ANLL)
Download Leaflet

Oncology

Xantomit®

Mitoxantrone is indicated for the treatment of multiple sclerosis, prostate cancer, hepatocellular carcinoma, breast cancer, non-hodgkin’s lymphoma, and acute non-lymphocytic leukemia (ANLL).

Apply for a Job Position

Curious about job opportunities?

Signup for a job

Products

Support

Company

Follow Us

© NanoAlvand. All rights reserved. Powered by ِDGN.